Prior stroke and neurological disability increased long-term mortality after myocardial infarction. Learn how neurological status may guide risk assessment.
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Acute myocardial infarction (AMI) continues to be a leading cause of death worldwide, necessitating rapid and accurate diagnosis to mitigate severe cardiac damage. The electrocardiogram (ECG) remains ...
Empagliflozin reduces heart failure hospitalization risk in patients with acute myocardial infarction, irrespective of type 2 diabetes or chronic kidney disease status. The EMPACT-MI trial showed a 23 ...
A risk-standardized model that includes patient factors, such as age and cardiogenic shock, can predict in-hospital mortality in patients with AMI. A new risk-standardized model can predict ...
INDIANAPOLIS, IND – The Canadian Cardiovascular Society (CCS) released the world’s first classification of acute myocardial infarction (AMI), or heart attack, based on heart tissue damage research ...
Even after adjusting for other risk factors, patients with COPD were more likely to be readmitted to the hospital with heart failure following an acute myocardial infarction, or heart attack. People ...
In a recent study published in JAMA, researchers investigated whether Tongxinluo, a Chinese medicinal compound, could improve clinical outcomes among ST-segment elevation myocardial infarction (STEMI) ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
Until the early 20th century, the human life expectancy was less than 50 years, and infections were often fatal. Only in the past century have humans, on average, lived long enough for cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results